• Users Online: 209
  • Print this page
  • Email this page

    Article Cited by others


New insights into the immunity and podocyte in glomerular health and disease: From pathogenesis to therapy in proteinuric kidney disease

Medina Rangel Paulina X, Priyadarshini Anupama, Tian Xuefei

Year : 2021| Volume: 8| Issue : 1 | Page no: 5-5

   This article has been cited by
1 Successful treatment of patients with refractory idiopathic membranous nephropathy with low-dose Rituximab: A single-center experience
Yao-Wei Wang, Xin-Hui Wang, Hong-Xia Wang, Ren-Huan Yu
World Journal of Clinical Cases. 2023; 11(3): 566
[Pubmed]  [Google Scholar] [DOI]
2 Case report: Successful outcome of treatment using rituximab in an adult patient with refractory minimal change disease and -thalassemia complicating autoimmune hemolytic anemia
Jing Zhuang, Zhigang Zhao, Changrong Zhang, Xue Song, Chen Lu, Xuefei Tian, Hong Jiang
Frontiers in Medicine. 2022; 9
[Pubmed]  [Google Scholar] [DOI]
3 Integrative phosphatidylcholine metabolism through phospholipase A2 in rats with chronic kidney disease
Yan-ni Wang, Zhi-hao Zhang, Hong-jiao Liu, Zhi-yuan Guo, Liang Zou, Ya-mei Zhang, Ying-yong Zhao
Acta Pharmacologica Sinica. 2022;
[Pubmed]  [Google Scholar] [DOI]
4 Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting I?B/NF-?B and Keap1/Nrf2 Signaling Pathways
Liang-Pu Luo, Ping Suo, Li-Li Ren, Hong-Jiao Liu, Yamei Zhang, Ying-Yong Zhao
Frontiers in Pharmacology. 2021; 12
[Pubmed]  [Google Scholar] [DOI]


Read this article